MedTwenty

Today's Twenty · Edition No. 2 · Saturday, 26 September 2026

300 stories screened. The twenty that matter.

LiveFinance & M&A

Tempus acquires Personalis in $1.5bn deal, deepening push into cancer genomics

The AI-diagnostics firm absorbs its oncology genomics partner three years after their initial collaboration — and sets up a direct contest with Foundation Medicine for NHS pathology contracts. Full deal terms, adviser detail and competitive landscape analysis in the intelligence database.

Oruaro Onibere · 4 min read

In this edition

Largest acquisition

$3.2bn

Optum → Landmark · Providers · Closed

Largest funding round

$340mSeries D

Abridge · Digital Health

Biggest regulatory approval

Oral PCSK9 inhibitor

Merck · NICE · Approved

MedTwenty IndicesMedTwenty Healthcare Index1011.9+0.42%MedTwenty Healthcare AI Index2135.3−0.21%MedTwenty Digital Health Index961.2+0.53%MedTwenty Diagnostics Index1297.1+0.63%MedTwenty M&A Activity Index444.8+0.50%MedTwenty Venture Capital Index789.8+0.46%

MedTwenty Indices and trackers are editorial indicators and business information. They are not investment, financial, legal or medical advice, and not a regulated benchmark.

300 stories screened. The twenty that matter.

Today's Twenty

Get it by email
  1. 2Premium

    Healthcare Business

    Medicare Advantage rate cuts reshape 2027 bids as plans retreat from rural markets

  2. 3Premium

    Pharma & Biotech

    Merck secures first approval for an oral PCSK9 inhibitor, reshaping the cholesterol market

  3. 4

    NHS & Policy

    NHS fast-tracks AI deployment across services in bid to tackle waiting lists

  4. 5Premium

    Digital Health

    Abridge raises $340m Series D to scale ambient AI across US health systems

  1. 6
    FDA extends Casgevy approval to children aged two and over, raising payer coverage questions

    MedTech & Devices

  2. 7
    Spire Healthcare appoints advisers as private hospital consolidation accelerates

    Private HealthcarePremium

  3. 8
    KKR completes Envision restructuring at $7.0bn, wiping out earlier equity

    Venture Capital & Private EquityPremium

  4. 9
    Paige raises $75m Series C to widen digital pathology footprint in Europe

    Diagnostics

  5. 10
    Hippocratic AI raises $175m Series B for clinical staffing agents

    Healthcare AI

  6. 11
    Optum closes $3.2bn Landmark acquisition, extending home-based care reach

    Finance & M&A

  7. 12
    Eko Health raises $125m Series C for cardiac AI at the point of care

    MedTech & Devices

  8. 13
    NHS 18-week compliance reaches 60.4% as elective recovery slows

    Hospitals

  9. 14
    Lilly agrees $2.8bn AtaiBeckley acquisition in neuropsychiatry push

    Pharma & Biotech

  10. 15
    BGO acquires Whitechapel life sciences campus for £750m

    Healthcare Business

  11. 16
    Viz.ai raises $100m Series D as stroke pathway AI reaches national scale

    Healthcare AI

  12. 17
    MHRA publishes updated guidance on adaptive AI medical devices

    NHS & Policy

  13. 18
    Pay review recommendations add £1.1bn to NHS provider cost base

    Workforce & Careers

  14. 19
    Japan opens reimbursement pathway for digital therapeutics

    Global Markets

  15. 20
    NHS Genomic Medicine Service widens whole-genome eligibility in paediatric oncology

    Precision Medicine

Deal and funding highlights

Open tracker
Deal Flow Tracker5 latest verified deals
  • Tempus → Personalis$1.5bn
  • Abridge$340m
  • Optum → Landmark$3.2bn
  • Spire Healthcare → [redacted]Undisclosed
  • Paige$75m
Open tracker →

Largest funding rounds

View all

Largest acquisitions

View all
  • KKR → Envision restructuring$7.0bn
  • Optum → Landmark$3.2bn
  • Lilly → AtaiBeckley$2.8bn
  • Tempus → Personalis$1.5bn
  • EQT → Nordic Care Group€1.1bn

Most active investors

View all

Trending technologies

View all

Featured research

Browse research centre
Market Analysis

NHS Procurement Intelligence Q2 2026

Contract awards, framework agreements, supplier performance and emerging procurement trends across England's integrated care systems.

36 pages · Updated monthly · Professional

Industry Outlook

Healthcare AI Market Forecast 2026–2030

Market sizing, competitive landscape and growth projections for ambient AI, diagnostic imaging, clinical decision support and drug discovery.

72 pages · Updated monthly · Enterprise

Premium Report

UK Healthcare Investment Outlook 2026

Comprehensive analysis of M&A, venture capital and private equity flows across NHS, independent providers, MedTech and digital health.

48 pages · Updated quarterly · Professional

Latest intelligence

View all news

Most read this week

  1. 1Tempus acquires Personalis in $1.5bn deal, deepening push into cancer genomicsFinance & M&A
  2. 2NHS fast-tracks AI deployment across services in bid to tackle waiting listsNHS & Policy
  3. 3Merck secures first approval for an oral PCSK9 inhibitor, reshaping the cholesterol marketPharma & Biotech
  4. 4Abridge raises $340m Series D to scale ambient AI across US health systemsDigital Health
  5. 5FDA extends Casgevy approval to children aged two and over, raising payer coverage questionsMedTech & Devices

Markets snapshot

  • MedTwenty Healthcare Index+0.42%
  • MedTwenty Healthcare AI Index−0.21%
  • MedTwenty Digital Health Index+0.53%
  • MedTwenty Diagnostics Index+0.63%
  • NHS 18-wk compliance61.3%

Featured companies

Browse companies
A

Abridge

Ambient AI

MedTwenty Score 92

O

Optum

Providers · Payers

MedTwenty Score 88

T

Tempus

Diagnostics · AI

MedTwenty Score 87

M

Merck

Pharmaceuticals

MedTwenty Score 85

V

Viz.ai

Stroke Detection · AI

MedTwenty Score 84

F

Foundation Medicine

Cancer Genomics

MedTwenty Score 81

Newsletters

Three free briefings from the intelligence desk

Every edition is drafted from verified database records and signed off by an editor before it sends.

See all newsletters
Choose your briefings

Intelligence products

Deal Flow TrackerEvery announced, completed and lapsed healthcare deal.Regulatory PipelineMHRA, NICE and FDA decisions as they land.NHS Waiting List MonitorMonthly referral-to-treatment figures by specialty.MedTwenty IndicesDaily indicators of healthcare business activity.Research CentreReports and outlooks built from the intelligence database.APICompany, deal and index data for your own systems.